BrainsWay Ltd. ( BWAY ) NASDAQ Global Market

Cena: 12.36 ( 7.57% )

Aktualizacja 06-24 20:23
NASDAQ Global Market
Branża: Medical - Devices

Notowania:


Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Devices
Zatrudnienie: 134
Giełda: NASDAQ Global Market
Ilość akcji w obrocie: 134%
Ilość akcji: 16 621 099
Debiut giełdowy: 2019-04-17
WWW: https://www.brainsway.com
CEO: Mr. Hadar Levy
Adres: Bynet Building
Siedziba: 9777518 Jerusalem
ISIN: US10501L1061
Opis firmy:

Brainsway Ltd. rozwija i sprzedaje nieinwazyjne leczenie neurostymulacji zaburzeń zdrowia psychicznego w Stanach Zjednoczonych, Europie, Izraelu i na arenie międzynarodowej. Oferuje technologię głębokiej przezczaszkową platformę stymulacji magnetycznej do leczenia poważnych zaburzeń depresyjnych, niespokojnej depresji, zaburzeń obsesyjno-kompulsyjnych, uzależnienia od palenia, zaburzeń dwubiegunowych, zaburzeń stresu po urazie, chorobami schizofrenii, choroby Alzheimera, autyzmu, przewlekłego bólu, stwardnienia rozsianego. Firma służy przede wszystkim lekarzom, szpitalom i centrom medycznym w dziedzinie psychiatrii. Brainsway Ltd. został założony w 2003 roku i ma siedzibę w Jerozolimie w Izraelu.

Wskaźniki finansowe
Kapitalizacja (USD) 233 540 346
Aktywa: 72 100 000
Cena: 12.36
Wskaźnik Altman Z-Score: 3.6
Stabilny (niskie ryzyko bankructwa)
Dywidenda: 0
P/E: 56.2
Ilość akcji w obrocie: 134%
Średni wolumen: 34 329
Ilość akcji 18 894 850
Wskaźniki finansowe
Przychody TTM 38 631 000
Zobowiązania: 28 072 000
Przedział 52 tyg.: 5.67 - 12.39
Piotroski F-Score: 5
Umiarkowany (średnia jakość finansowa)
EPS: 0.2
P/E branży: 26.8
Beta: 0.374
Raport okresowy: 2025-08-04
WWW: https://www.brainsway.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Prof. Abraham Zangen Co-Founder, Member of Scientific Advisory Board & Director 72 175 1970
Mr. Hadar Levy Chief Executive Officer 434 000 1974
Mr. Avner Hagai Founder & Director 43 646 1956
Dr. Yiftach Roth Ph.D. Founder & Chief Scientific Officer 108 000 1971
Mr. Gilead Moiseyev Chief Technology Officer 0 0
Mr. Ross Mitchell Vice President of Global Marketing 0 0
Mr. Ido Marom Chief Financial Officer 0 1976
Mr. Menachem C. Klein Esq. Vice President, General Counsel & Corporate Secretary 0 0
Ms. Hillegonda Groen Vice President of International Sales 0 1969
Wiadomości dla BrainsWay Ltd.
Tytuł Treść Źródło Aktualizacja Link
BrainsWay Ltd. (BWAY) Q1 2025 Earnings Call Transcript BrainsWay Ltd. (NASDAQ:BWAY ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Brian Ritchie – LifeSci Advisors LLC Hadar Levy – Chief Executive Officer Ido Marom – Chief Financial Officer Conference Call Participants Steve Lichtman – Oppenheimer & Company Operator Good day, and welcome to the BrainsWay First Quarter 2025 Earnings Conference Call. seekingalpha.com 2025-05-13 14:16:19 Czytaj oryginał (ang.)
BrainsWay Reports First Quarter 2025 Financial Results and Operational Highlights Achieved r ecord quarterly s ales of $11. 5 million in Q 1 202 5 , an increase of 27% compared to Q 1 202 4 globenewswire.com 2025-05-13 11:30:00 Czytaj oryginał (ang.)
BrainsWay Ltd. (BWAY) Q4 2024 Earnings Call Transcript BrainsWay Ltd. (NASDAQ:BWAY ) Q4 2024 Earnings Conference Call March 11, 2025 8:30 AM ET Company Participants Brian Ritchie - Investor Relations, LifeSci Advisors Hadar Levy - Chief Executive Officer Ido Marom - Chief Financial Officer Conference Call Participants Steven Lichtman - Oppenheimer Jeffrey S. seekingalpha.com 2025-03-11 12:17:23 Czytaj oryginał (ang.)
BrainsWay Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights Achieved r ecord quarterly s ales of $11.4 million in Q4 2024 , an increase of 27% compared with Q4 2023 globenewswire.com 2025-03-11 09:30:00 Czytaj oryginał (ang.)
BWAY Drops 15% in Four Days: How to Play the Stock Before Earnings? BrainsWay  BWAY shares plunged 15.7% in the past four trading sessions, falling below the 50-day moving average, implying weakness in the stock. Meanwhile, BWAY is scheduled to release its fourth-quarter results on March 11. zacks.com 2025-02-25 12:41:08 Czytaj oryginał (ang.)
Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why If you are looking for stocks that are well positioned to maintain their recent uptrend, Brainsway (BWAY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen. zacks.com 2025-02-21 11:50:29 Czytaj oryginał (ang.)
Brainsway Ltd. Sponsored ADR (BWAY) Hit a 52 Week High, Can the Run Continue? Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. zacks.com 2025-02-17 12:16:15 Czytaj oryginał (ang.)
5 Stocks With Recent Price Strength to Enhance Your Portfolio Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are SBFG, FCCO, SNEX, BYRN, BWAY. zacks.com 2025-02-13 10:40:40 Czytaj oryginał (ang.)
4 Top-Ranked Solid Net Profit Margin Stocks to Boost Portfolio Returns Let us take a look at four top-ranked stocks, AVO, ACEL, BWAY and FRBA, with stellar net profit margins that can help create a winning portfolio. zacks.com 2025-02-06 11:01:26 Czytaj oryginał (ang.)
3 Top-Ranked Breakout Stocks to Buy Now: BWB, EBC, BWAY Bridgewater Bancshares, Eastern Bankshares and BrainsWay have been selected as the breakout stocks for today. zacks.com 2025-02-06 10:21:14 Czytaj oryginał (ang.)
Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable If you are looking for stocks that are well positioned to maintain their recent uptrend, Brainsway (BWAY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen. zacks.com 2025-02-05 11:51:41 Czytaj oryginał (ang.)
Brainsway Ltd. Sponsored ADR (BWAY) Soars to 52-Week High, Time to Cash Out? Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. zacks.com 2025-01-22 12:15:20 Czytaj oryginał (ang.)
Brainsway (BWAY) Moves 8.0% Higher: Will This Strength Last? Brainsway (BWAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road. zacks.com 2025-01-22 10:41:10 Czytaj oryginał (ang.)
Recent Price Trend in Brainsway (BWAY) is Your Friend, Here's Why If you are looking for stocks that are well positioned to maintain their recent uptrend, Brainsway (BWAY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen. zacks.com 2025-01-16 11:56:11 Czytaj oryginał (ang.)
Earnings Estimates Rising for Brainsway (BWAY): Will It Gain? Brainsway (BWAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions. zacks.com 2025-01-15 15:21:12 Czytaj oryginał (ang.)
Wall Street Analysts Think Brainsway (BWAY) Could Surge 38.83%: Read This Before Placing a Bet The average of price targets set by Wall Street analysts indicates a potential upside of 38.8% in Brainsway (BWAY). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. zacks.com 2025-01-15 12:55:24 Czytaj oryginał (ang.)
New Strong Buy Stocks for January 14th BWAY, EE, MATW, BRBR and FMAO have been added to the Zacks Rank #1 (Strong Buy) List on January 14, 2025. zacks.com 2025-01-14 09:16:13 Czytaj oryginał (ang.)
Are Medical Stocks Lagging Brainsway (BWAY) This Year? Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Butterfly Network, Inc. (BFLY) have performed compared to their sector so far this year. zacks.com 2024-12-26 12:40:30 Czytaj oryginał (ang.)
BrainsWay Reports Positive Independent Pilot Data on Accelerated Deep TMS Treatment of Alcohol Use Disorder BURLINGTON, Mass. and JERUSALEM, Dec. 12, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today announced recent positive pilot data from an independent, third-party study conducted at Stanford University evaluating an accelerated protocol using the Company's Deep Transcranial Magnetic Stimulation (TMS) technology to treat alcohol use disorder (AUD) patients. The outcomes were reported in a publication in the Brain Stimulation journal entitled, “Accelerated deep TMS in alcohol use disorder: A preliminary pilot trial targeting the dorsal anterior cingulate cortex increases neural target engagement and abstinence.” globenewswire.com 2024-12-12 10:00:00 Czytaj oryginał (ang.)
BrainsWay Reports Promising Feasibility Data Showing Pain Reduction with Deep TMS Therapy BURLINGTON, Mass. and JERUSALEM, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. globenewswire.com 2024-11-20 10:00:00 Czytaj oryginał (ang.)
BrainsWay Ltd. (BWAY) Q3 2024 Earnings Call Transcript BrainsWay Ltd. (NASDAQ:BWAY ) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Brian Ritchie - IR, LifeSci Advisors Hadar Levy - CEO Ido Marom - CFO Conference Call Participants Steven Lichtman - Oppenheimer Jeff Cohen - Ladenburg Thalmann & Company Operator Good day, and welcome to the BrainsWay Third Quarter 2024 Earnings Conference Call. seekingalpha.com 2024-11-12 14:59:07 Czytaj oryginał (ang.)
BrainsWay Reports Third Quarter 2024 Financial Results and Operational Highlights Robust 26% Year-over-Year Revenue Growth in Q3 2024 Raising Full-Year 2024 Revenue Guidance to $40-41 Million and Initiating Profitability Guidance Conference Call to be Held Today at 8:30 AM ET BURLINGTON, Mass. and JERUSALEM, Israel, Nov. 12, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. globenewswire.com 2024-11-12 09:30:00 Czytaj oryginał (ang.)
Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why Brainsway (BWAY) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen. zacks.com 2024-11-06 11:51:19 Czytaj oryginał (ang.)
Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year? Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year. zacks.com 2024-10-31 12:45:53 Czytaj oryginał (ang.)
BrainsWay to Report Third Quarter 2024 Financial Results On November 12, 2024 BURLINGTON, Mass. and JERUSALEM, Oct. 29, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its third quarter 2024 financial results as well as operational highlights before the open of the U.S. financial markets on Tuesday, November 12, 2024. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations. globenewswire.com 2024-10-29 10:00:00 Czytaj oryginał (ang.)
Wall Street Analysts Believe Brainsway (BWAY) Could Rally 32.01%: Here's is How to Trade The consensus price target hints at a 32% upside potential for Brainsway (BWAY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. zacks.com 2024-10-21 14:55:19 Czytaj oryginał (ang.)
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run? Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. zacks.com 2024-10-21 14:16:12 Czytaj oryginał (ang.)
Here's Why Momentum in Brainsway (BWAY) Should Keep going Brainsway (BWAY) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen. zacks.com 2024-10-21 13:50:37 Czytaj oryginał (ang.)
Are Medical Stocks Lagging Brainsway (BWAY) This Year? Here is how Brainsway Ltd. Sponsored ADR (BWAY) and Intuitive Surgical, Inc. (ISRG) have performed compared to their sector so far this year. zacks.com 2024-10-15 14:45:55 Czytaj oryginał (ang.)
BrainsWay Further Penetrates East Asia with Placement of 15 Additional Deep TMS™ Systems in Taiwan and South Korea BURLINGTON, Mass. and JERUSALEM, Israel, Oct. 09, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the further expansion of its Deep Transcranial Magnetic Stimulation (Deep TMS™) platform in East Asia through the placement of 15 new systems in Taiwan and South Korea. globenewswire.com 2024-10-09 11:30:00 Czytaj oryginał (ang.)
Does Brainsway (BWAY) Have the Potential to Rally 34.38% as Wall Street Analysts Expect? The consensus price target hints at a 34.4% upside potential for Brainsway (BWAY). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. zacks.com 2024-10-04 14:56:07 Czytaj oryginał (ang.)
Brainsway Ltd. Sponsored ADR (BWAY) Hits Fresh High: Is There Still Room to Run? Brainsway (BWAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. zacks.com 2024-10-04 14:15:19 Czytaj oryginał (ang.)
Brainsway (BWAY) is on the Move, Here's Why the Trend Could be Sustainable Brainsway (BWAY) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen. zacks.com 2024-10-04 13:51:19 Czytaj oryginał (ang.)
Brainsway (BWAY) Soars 14.5%: Is Further Upside Left in the Stock? Brainsway (BWAY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. zacks.com 2024-10-01 13:30:31 Czytaj oryginał (ang.)
BrainsWay Announces US$20 Million Private Placement with Valor Equity Partners Company to leverage capital and Valor's expertise for strategic initiatives building market awareness, R&D roadmap, data analysis capabilities, and expanding access to Deep TMS™ globenewswire.com 2024-09-30 11:30:00 Czytaj oryginał (ang.)
Recent Price Trend in Brainsway (BWAY) is Your Friend, Here's Why Brainsway (BWAY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move. zacks.com 2024-09-18 13:56:25 Czytaj oryginał (ang.)
5 Stocks With Recent Price Strength to Enhance Your Portfolio Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are BYRN, IDR, LMB, SEZL, BWAY. zacks.com 2024-09-18 11:01:04 Czytaj oryginał (ang.)